Wednesday, November 25, 2015 8:57:53 PM
We also learn that Staphylococcus species cannot hide from the MIT 1000, meaning that all strains of staff can be now be detected.
Another thing we now know is that some very important people who can be in the line of sales someday have used and tested the machine, and gave a wild, important update on performance.
With such ACCURATE performance of the MIT 1000 within the camp of the hospital industry microbiological departments, it leaves little to the imagination as to where Micro Imaging Technologies, Inc, is headed. This direction of the company has a long shelf life of action that all investors can trust. As such, the price of the stock should be rising over time and not dropping. Overall, there could come dips on the way; however, it is plainly obvious that updates to this press release will be coming and are expected.
http://www.micro-imaging.com/mit-blog
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM